Chief Strategy Officer Prior Stephen David sold AN2 Therapeutics Inc. ($ANTX) shares on the open market three times over the past year, totaling about $7,379. His most recent sale occurred on January 6, 2026. These sales rank 11,336th among 11,678 insiders in our database, where the average is $8.6 million across about 6.4 transactions. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 5, 2026 | AN2 Therapeutics, Inc. | $ANTX | Prior Stephen David | Chief Strategy Officer | S | Common Stock | 3604 | $1.00 | 61,944.0000 | 30,276,230 | 5.50% | 0.01% |
| Jan. 6, 2026 | AN2 Therapeutics, Inc. | $ANTX | Prior Stephen David | Chief Strategy Officer | S | Common Stock | 2858 | $1.01 | 59,086.0000 | 30,276,230 | 4.61% | 0.01% |
| Nov. 4, 2025 | AN2 Therapeutics, Inc. | $ANTX | Prior Stephen David | Chief Strategy Officer | S | Common Stock | 765 | $1.14 | 65,548.0000 | 30,276,230 | 1.15% | 0.00% |
| Feb. 26, 2025 | AN2 Therapeutics, Inc. | $ANTX | Prior Stephen David | Chief Strategy Officer | A | Common Stock | 28000 | $0.00 | 61,313.0000 | 29,828,227 | 84.05% | 0.09% |
| Feb. 26, 2025 | AN2 Therapeutics, Inc. | $ANTX | Prior Stephen David | Chief Strategy Officer | A | Stock Option (right to buy) | 56000 | $0.00 | 56,000.0000 | 29,828,227 | 9999.99% | 0.19% |
| Jan. 3, 2025 | AN2 Therapeutics, Inc. | $ANTX | Prior Stephen David | Chief Strategy Officer | S | Common Stock | 2029 | $1.34 | 33,313.0000 | 29,828,227 | 5.74% | 0.01% |
| Nov. 4, 2024 | AN2 Therapeutics, Inc. | $ANTX | Prior Stephen David | Chief Strategy Officer | A | Stock Option (right to buy) | 20250 | $0.00 | 20,250.0000 | 29,841,169 | 9999.99% | 0.07% |
| Nov. 4, 2024 | AN2 Therapeutics, Inc. | $ANTX | Prior Stephen David | Chief Strategy Officer | A | Common Stock | 10125 | $0.00 | 35,342.0000 | 29,841,169 | 40.15% | 0.03% |